Author has spent 400 hours researching OPTX and holds 500,000 warrants (up 1,162% from $0.22 avg cost). The thesis relies on a June 26 Russell 3000 reconstitution that will force $12-20M of passive buying into a small tradeable float while 17% of shares are currently shorted, creating a potential squeeze to the author's $25 stock price target (representing ~6,000% total gain from original cost).

Author claims 400 hours of research on OPTX, a company with fundamentals (production quadrupled, revenue ramp, major contracts) strengthened by Russell 3000 inclusion on June 26 forcing $12-20M in passive buying. Key risks: 17% short float could squeeze unpredictably, warrant leverage amplifies downside, Russell inclusion is priced-in, execution risk on revenue ramp.